Tag: novel coronavirus ; SARS-CoV-2

Australia Reports Second AstraZeneca Blood Clot Case

SYDNEY (Reuters) – Australia said on Tuesday a second person had been diagnosed with a blood clot after receiving the AstraZeneca Plc vaccine but there had been no rise in inoculation cancellations as authorities try to steady a bungled immunisation campaign. This week Australia abandoned a goal of vaccinating all of its nearly 26 million

Ontario Hospitals May Have to Withhold Care as COVID-19 Fills ICUs

TORONTO (Reuters) – Doctors in the Canadian province of Ontario may soon have to decide who can and cannot receive treatment in intensive care as the number of coronavirus infections sets records and patients are packed into hospitals still stretched from a December wave. Canada’s most populous province is canceling elective surgeries, admitting adults to

COVID-19 Vaccination Strategies Suggested for Patients on Antirheumatic Immunosuppressive Therapy

NEW YORK (Reuters Health) – UK experts propose evidence-based management strategies for rheumatology patients on immunosuppressive therapy, including delaying/postponing rituximab, as appropriate. “The aim of this viewpoint article is to outline the existing data on the effect of antirheumatic therapy on vaccine responses in patients with inflammatory arthritis, and to formulate a possible pragmatic strategy

Toxic Metabolic Encephalopathy a Risk Factor for Death in Severe COVID-19

NEW YORK (Reuters Health) – Toxic metabolic encephalopathy (TME) not due to the effects of sedative medications occurred in one in eight patients hospitalized for COVID-19 at NYU Langone Health hospitals last spring, neurologists report. TME was multifactorial in these patients and most often due to hypoxemia, sepsis and uremia. After adjusting for confounding factors,